Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management

Overview of attention for article published in Clinical and Experimental Gastroenterology, June 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter: 7 X users

facebook: 1 Facebook page

Readers on

mendeley: 6 Mendeley

Summary X Facebook

So far, Altmetric has seen 12 X posts from 7 X users, with an upper bound of 5,427 followers.

$ARDX also addresses HTN and CHF via NHE3 inhibition https://t.co/itjkR9D8pB Renal bundle of targets.

09 Nov 2023

Reply Repost Favourite

RT @TonyFauci2: There is ONLY 1 Treatment for Constipation that relieves renal patients’ constipation as it relieves Renal patients’ Cardia…

09 Nov 2023

Reply Repost Favourite

There is ONLY 1 Treatment for Constipation that relieves renal patients’ constipation as it relieves Renal patients’ Cardiac threatening Hyperphosphatemia- $ARDX Tenanapor - also known as IBSRELA and XPHOZAH. https://t.co/1HcR4QReKG #Dovetailed

08 Nov 2023

Reply Repost Favourite

RT @TonyFauci2: $ARDX IBSRELA (Tenanapor - XPHOZAH) https://t.co/1HcR4QReKG ✔️ https://t.co/oj0hVi5C1D

08 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.